Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy   Report issue

Academic/Hospital Phase 4
Founded: Palermo Italy (2001)

Organization Overview

First Clinical Trial
2014
NCT02507245
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy

Active Ingredients

Drugs in Phase 4 Trials (5)

beclomethasone (vanceril) (2 trials)

budesonide (rhinocort) (1 trial)

carboxymethyl glucan (1 trial)

resveratrol (1 trial)

sodium chloride (1 trial)

Drugs in Other Trials (1)

somatorelin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 4)

Respiratory Sounds (Phase 4)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 6